Rajendra Singh Garbyal
Overview
Explore the profile of Rajendra Singh Garbyal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
62
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Iden C, Mustafa S, Ogaard N, Henriksen T, Jensen S, Ahlborn L, et al.
Gastric Cancer
. 2024 Oct;
28(1):83-95.
PMID: 39369091
Background: Gastric and gastroesophageal junction (GEJ) cancer represents a significant global health challenge, with high recurrence rates and poor survival outcomes. This study investigates circulating tumor DNA (ctDNA) as a...
2.
Andreassen M, Garbyal R, Larsen P, Hansen C, Hannibal J, Oturai P, et al.
J Surg Case Rep
. 2024 Jun;
2024(5):rjae371.
PMID: 38826856
This case report presents a 40-year-old patient with a vasoactive intestinal peptide (VIP) secreting high grade (Ki-67 39%) neuroendocrine tumor (NET) from the pancreas, for whom successful liver transplantation (LT)...
3.
Petersen S, Moller S, Slott C, Krogh J, Hansen C, Kjaer A, et al.
Cancers (Basel)
. 2024 Mar;
16(6).
PMID: 38539524
Background: Given the rarity and heterogeneity of pancreatic neuroendocrine neoplasms (pNEN), treatment algorithms and sequencing are primarily guided by expert opinions with limited evidence. Aim: To investigate overall survival (OS),...
4.
Slott C, Langer S, Moller S, Krogh J, Klose M, Hansen C, et al.
Cancers (Basel)
. 2024 Jan;
16(1).
PMID: 38201631
Background: Small intestinal neuroendocrine tumors (siNET) are one of the most common neuroendocrine neoplasms. Radical surgery is the only curative treatment. Method: We utilized a single-center study including consecutive patients...
5.
Moller S, Langer S, Slott C, Krogh J, Hansen C, Kjaer A, et al.
Cancers (Basel)
. 2024 Jan;
16(1).
PMID: 38201527
Introduction: The prognosis and impact of different prognostic factors in pancreatic neuroendocrine neoplasms (pNEN) remain controversial. Aim: To investigate prognostic factors for recurrence-free survival and disease-specific survival in patients with...
6.
Holmager P, Langer S, Kjaer A, Ringholm L, Garbyal R, Hansen C, et al.
Curr Oncol Rep
. 2024 Jan;
26(2):114-120.
PMID: 38168835
Purpose Of Review: To summarize the literature from the last 5 years on treatment of appendiceal neuroendocrine neoplasms (aNEN). Furthermore, to evaluate the prognostic significance of lymph node metastases, indications...
7.
Egeland C, Balsevicius L, Gogenur I, Gehl J, Baeksgaard L, Garbyal R, et al.
J Cancer Res Clin Oncol
. 2023 Sep;
149(17):16031-16042.
PMID: 37688629
Purpose: In this study, we aim to investigate gene expression changes in tumor samples obtained from patients with esophageal cancer treated with calcium electroporation. Previously, local treatment with calcium electroporation...
8.
Holmager P, Langer S, Kjaer A, Ringholm L, Garbyal R, Pommergaard H, et al.
Curr Treat Options Oncol
. 2022 Apr;
23(6):806-817.
PMID: 35362798
In the 2019 WHO guidelines, the classification of gastro-entero-pancreatic neuroendocrine neoplasms (GEP NEN) has changed from one being based on Ki-67 proliferation index alone to one that also includes tumor...
9.
Holmager P, Langer S, Federspiel B, Willemoe G, Garbyal R, Melchior L, et al.
J Neuroendocrinol
. 2021 Aug;
33(9):e13018.
PMID: 34414612
An increase in the Ki-67 index in neuroendocrine neoplasms over time in relation to prognosis has scarcely been investigated. We aimed to assess whether the Ki-67 index changed over time...
10.
Achiam M, Nordsmark M, Ladekarl M, Olsen A, Loft A, Garbyal R, et al.
Acta Oncol
. 2021 Jul;
60(9):1091-1099.
PMID: 34313177
Background: Decisions regarding tumor staging, operability, resectability, and treatment strategy in patients with esophageal cancer are made at multidisciplinary team (MDT) conferences. We aimed to assess interobserver agreement from four...